Literature DB >> 7663976

Allogeneic grafts of fetal dopamine neurons: immunological reactions following active and adoptive immunizations.

M Shinoda1, J L Hudson, I Strömberg, B J Hoffer, J W Moorhead, L Olson.   

Abstract

To define the importance of adoptive sensitization and duration of graft residence on transplant alloimmunization, behavioral and histochemical parameters were examined in unilaterally 6-OHDA-lesioned F344 rat hosts which received fetal ventral mesencephalic (VM) grafts from Wistar-Furth (WF) donors. In all animals which showed increased rotations after alloimmunization, increased numbers of T cell receptor (TcR) positive, CD8+ lymphocytes were detected in the grafts. In addition, an increased density of class I MHC antigens was seen in the graft and in the adjacent host brain. Lesser numbers of CD4+, CD11b+, and MHCII+ positive elements were also seen. Perivascular cuffing was often found in actively immunized animals. An increase in TcR+ and MHC class I+ elements was also seen in animals only adoptively immunized. The tyrosine hydroxylase positive graft area was also markedly reduced in actively immunized animals and the extent of reduction correlated with the number of cells used for immunization. These studies indicate that established allografts can evade rejection as long as host lymphocytes are not activated against graft alloantigens. In addition, increasing graft residence time in the host and adoptive immunization render the graft more susceptible to subsequent rejection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7663976     DOI: 10.1016/0006-8993(95)00260-w

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Cell therapy in Parkinson's disease.

Authors:  Olle Lindvall; Anders Björklund
Journal:  NeuroRx       Date:  2004-10

2.  Differential activation of astrocytes and microglia after spinal cord injury in the fetal rat.

Authors:  Yoshinori Fujimoto; Takeshi Yamasaki; Nobuhiro Tanaka; Yu Mochizuki; Hiroki Kajihara; Yoshikazu Ikuta; Mitsuo Ochi
Journal:  Eur Spine J       Date:  2005-11-16       Impact factor: 3.134

Review 3.  Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?

Authors:  Marina Romero-Ramos; Marianne von Euler Chelpin; Vanesa Sanchez-Guajardo
Journal:  Hum Vaccin Immunother       Date:  2014-03-26       Impact factor: 3.452

4.  Differential immune responses to fetal intracameral spinal cord and cortex cerebri grafts.

Authors:  M Shinoda; M Giacobini; R Schmidt-Kastner; K Trok; L Olson
Journal:  Exp Brain Res       Date:  1996-07       Impact factor: 1.972

5.  Understanding and prevention of "therapy-" induced dyskinesias.

Authors:  Iciar Aviles-Olmos; Zinovia Kefalopoulou; Thomas Foltynie
Journal:  Parkinsons Dis       Date:  2012-05-23

6.  Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate.

Authors:  Asuka Morizane; Daisuke Doi; Tetsuhiro Kikuchi; Keisuke Okita; Akitsu Hotta; Toshiyuki Kawasaki; Takuya Hayashi; Hirotaka Onoe; Takashi Shiina; Shinya Yamanaka; Jun Takahashi
Journal:  Stem Cell Reports       Date:  2013-09-26       Impact factor: 7.765

7.  hESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation.

Authors:  Andreas Heuer; Agnete Kirkeby; Ulrich Pfisterer; Marie E Jönsson; Malin Parmar
Journal:  Exp Neurol       Date:  2016-05-25       Impact factor: 5.330

Review 8.  The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson's disease.

Authors:  Shamma Qarin; Sarah K Howlett; Joanne L Jones; Roger A Barker
Journal:  Neuronal Signal       Date:  2021-09-13

9.  L-dopa-Dependent Effects of GLP-1R Agonists on the Survival of Dopaminergic Cells Transplanted into a Rat Model of Parkinson Disease.

Authors:  Osama F Elabi; Jeffrey S Davies; Emma L Lane
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.